PRMT3 and axial length measurement: As PRMT3 degraders may have unparalleled benefits over conventional PRMT3 inhibitors in therapeutic treatment, our data suggest that 11 can be a promising chemical probe for PRMT3‐related disease research, in addition to its potential use for the treatment of AL.